Related Experiment Video

Updated: May 16, 2026

Methyl-binding DNA capture Sequencing for Patient Tissues
08:40

Methyl-binding DNA capture Sequencing for Patient Tissues

Published on: October 31, 2016

The methylation landscape of tumour metastasis

Alicia Cock-Rada1, Jonathan B Weitzman

  • 1Unidad de Genética Médica, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.

Biology of the Cell
|December 4, 2012
PubMed

Insights

Epigenetic alterations, including DNA and histone methylation, drive cancer metastasis. Understanding these reversible changes offers new biomarkers and therapeutic targets for advanced cancer.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Cancer metastasis is a multi-step process driven by genetic and epigenetic changes.
  • Epigenetic mechanisms, particularly DNA methylation and histone modifications, are altered in cancer cells, affecting gene expression.
  • The role of methylation in advanced metastasis is less understood than in initial oncogenesis.

Purpose of the Study:

  • To elucidate the role of epigenetic mechanisms, specifically DNA and histone methylation, in cancer metastasis.
  • To identify potential biomarkers and therapeutic targets for advanced cancer based on methylation events.
  • To improve understanding of gene regulation in the metastatic cascade.

Main Methods:

  • Review of current literature on DNA methylation and histone post-translational modifications in cancer.
  • Analysis of the impact of methylating enzymes on gene expression and metastatic phenotypes.
  • Discussion of the reversibility of epigenetic modifications as biomarkers and therapeutic targets.

Main Results:

  • The methylation landscape is significantly altered in cancer cells, influencing genes that control tumor phenotypes.
  • Histone-modifying enzymes play active roles in cancer progression by regulating genes associated with metastasis.
  • Both DNA methylation and histone-tail methylation are implicated in oncogenesis and metastasis formation.

Conclusions:

  • Epigenetic modifications, specifically DNA and histone methylation, are critical regulators of cancer metastasis.
  • The reversibility of these methylation events presents promising opportunities for developing biomarkers and novel therapeutic strategies for advanced cancer.
  • Further research into methylation patterns can lead to innovative diagnostic and treatment approaches for cancer patients.

More Related Videos

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...